Literature DB >> 20827406

Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then.

Mehnaaz Sultan Khuroo, Mohammad Sultan Khuroo.   

Abstract

PURPOSE: Large-scale waterborne epidemics of hepatitis E occur in developing countries. It is not known why these epidemics occur repeatedly and selectively in adult population?
METHODS: We studied seroepidemiology of an outbreak of hepatitis E in one of 15 villages that had recorded first epidemic of hepatitis E 30 years back. Another village not affected by the second epidemic was taken as a control. Overall, 1,216 sera were collected (638 from the epidemic village and 578 from the control village) for serological markers of both hepatitis A virus (HAV) and hepatitis E virus (HEV).
RESULTS: The seroprevalence of anti-HEV in this population following the first epidemic in 1978 was 29.4%. Antibodies were detected in only 47% of the 45 patients affected by icteric HEV infection 14 years after the first epidemic. At 30-year follow-up, the seroprevalence of anti-HEV was only 4.5% (26/578). In the village affected by second epidemic, 138 (21.6%) subjects had serological evidence of recent HEV infection. The attack rate was 23.6% (78/330) in children (≤14 years) and 19.4% (60/308) in adults (P = 0.21). The attack rate of anicteric HEV infection was 21.8% (72/330) in children and 14.6% (45/308) in adults (P = 0.02).
CONCLUSIONS: Following hepatitis E epidemics, there is a gradual loss of antibodies in the community over the decades and poor exposure to HEV infection in the cohort of population born during the interepidemic period. The next epidemic occurs when antibody levels fall to critically low levels and there is associated gross fecal contamination of water resources. During epidemic, persons of all age groups are exposed to infection, with predominant anicteric disease in children.

Entities:  

Keywords:  Anti-HEV; Epidemic; Epidemiology; Hepatitis A virus; Hepatitis E virus; Kashmir

Year:  2010        PMID: 20827406      PMCID: PMC2900553          DOI: 10.1007/s12072-009-9159-5

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  17 in total

1.  Prevalence of antibodies to hepatitis E in two rural Egyptian communities.

Authors:  A D Fix; M Abdel-Hamid; R H Purcell; M H Shehata; F Abdel-Aziz; N Mikhail; H el Sebai; M Nafeh; M Habib; R R Arthur; S U Emerson; G T Strickland
Journal:  Am J Trop Med Hyg       Date:  2000-04       Impact factor: 2.345

2.  Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis.

Authors:  G R Reyes; M A Purdy; J P Kim; K C Luk; L M Young; K E Fry; D W Bradley
Journal:  Science       Date:  1990-03-16       Impact factor: 47.728

3.  Hepatitis E vaccine--ready for prime time?

Authors:  Krzysztof Krawczynski
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

4.  Hepatitis E and long-term antibody status.

Authors:  M S Khuroo; S Kamili; M Y Dar; R Moecklii; S Jameel
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

5.  Safety and efficacy of a recombinant hepatitis E vaccine.

Authors:  Mrigendra Prasad Shrestha; Robert McNair Scott; Durga Man Joshi; Mammen P Mammen; Gyan Bahadur Thapa; Narbada Thapa; Khin Saw Aye Myint; Marc Fourneau; Robert A Kuschner; Sanjaya Kumar Shrestha; Marie Pierre David; Jitvimol Seriwatana; David W Vaughn; Assad Safary; Timothy P Endy; Bruce L Innis
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

Review 6.  Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention.

Authors:  Isa K Mushahwar
Journal:  J Med Virol       Date:  2008-04       Impact factor: 2.327

7.  Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992.

Authors:  V A Arankalle; S A Tsarev; M S Chadha; D W Alling; S U Emerson; K Banerjee; R H Purcell
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

Review 8.  Hepatitis E virus.

Authors:  Mohammad S Khuroo; Mehnaaz S Khuroo
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

9.  Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology.

Authors:  D C Wong; R H Purcell; M A Sreenivasan; S R Prasad; K M Pavri
Journal:  Lancet       Date:  1980-10-25       Impact factor: 79.321

10.  Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection.

Authors:  Sharda Patra; Ashish Kumar; Shubha Sagar Trivedi; Manju Puri; Shiv Kumar Sarin
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391

View more
  11 in total

1.  Hepatitis E: are psychiatric patients on special risk?

Authors:  Claudia Reinheimer; Regina Allwinn; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2011-10-18       Impact factor: 3.402

2.  Hepatitis E: Epidemiology and prevention.

Authors:  Eyasu H Teshale; Dale J Hu
Journal:  World J Hepatol       Date:  2011-12-27

Review 3.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

Review 4.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 5.  Hepatitis E: Discovery, global impact, control and cure.

Authors:  Mohammad S Khuroo; Mehnaaz S Khuroo; Naira S Khuroo
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

6.  Ingesting Self-Grown Produce and Seropositivity for Hepatitis E in the United States.

Authors:  Thomas M Diehl; Daniel J Adams; Cade M Nylund
Journal:  Gastroenterol Res Pract       Date:  2018-07-15       Impact factor: 2.260

7.  Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China.

Authors:  Brittany L Kmush; Huan Yu; Shoujie Huang; Xuefang Zhang; Ting Wu; Kenrad E Nelson; Alain B Labrique
Journal:  Open Forum Infect Dis       Date:  2019-03-28       Impact factor: 3.835

8.  Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: strong association with HIV and environmental enteropathy.

Authors:  Choolwe Jacobs; Clarance Chiluba; Cynthia Phiri; Mpala Mwanza Lisulo; Mumba Chomba; Philip C Hill; Samreen Ijaz; Paul Kelly
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

Review 9.  Transmission of Hepatitis E Virus in Developing Countries.

Authors:  Mohammad S Khuroo; Mehnaaz S Khuroo; Naira S Khuroo
Journal:  Viruses       Date:  2016-09-20       Impact factor: 5.048

10.  Setting a Course for Preventing Hepatitis E in Low and Lower-Middle-Income Countries: A Systematic Review of Burden and Risk Factors.

Authors:  Aybüke Koyuncu; Daniel Mapemba; Iza Ciglenecki; Emily S Gurley; Andrew S Azman
Journal:  Open Forum Infect Dis       Date:  2021-04-13       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.